- Home
- BTMD vs RFM Comparison
BTMD vs RFM Comparison
Compare BTMD & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTMD | RFM |
|---|---|---|
| Founded | 2012 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 85.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BTMD | RFM |
|---|---|---|
| Price | $2.45 | $14.01 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 124.9K | 20.7K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.74% |
| EPS Growth | ★ 270.48 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $195,645,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.80 | N/A |
| P/E Ratio | $3.34 | ★ N/A |
| Revenue Growth | ★ 1.34 | N/A |
| 52 Week Low | $2.32 | $12.89 |
| 52 Week High | $6.36 | $16.41 |
Technical Indicators
Market Signals| Indicator | BTMD | RFM |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | 41.73 |
| Support Level | $2.56 | $13.86 |
| Resistance Level | $2.80 | $14.04 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 1.14 | 35.37 |
Price Performance
Historical ComparisonAbout BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.